Compounds > tadalafil
Page last updated: 2024-09-02

tadalafil and quisinostat

tadalafil has been researched along with quisinostat in 1 studies

Compound Research Comparison

Studies
(tadalafil)		Trials
(tadalafil)		Recent Studies (post-2010)
(tadalafil)		Studies
(quisinostat)		Trials
(quisinostat)		Recent Studies (post-2010) (quisinostat)
1,7423921,08971363

Protein Interaction Comparison

ProteinTaxonomytadalafil (IC50)quisinostat (IC50)
Histone deacetylase 8Schistosoma mansoni0.3034
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.039
Histone deacetylase 3Homo sapiens (human)0.0039
Cytochrome P450 3A4Homo sapiens (human)0.0001
Cytochrome P450 2D6Homo sapiens (human)0.0001
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.019
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.054
Histone deacetylase 4Homo sapiens (human)0.0026
Histone deacetylase 1Homo sapiens (human)0.0009
Histone deacetylase 7Homo sapiens (human)0.0424
Histone deacetylase 2Homo sapiens (human)0.0018
Polyamine deacetylase HDAC10Homo sapiens (human)0.0082
Histone deacetylase 11 Homo sapiens (human)0.0004
Histone deacetylase 8Homo sapiens (human)0.078
Histone deacetylase 6Homo sapiens (human)0.0664
Histone deacetylase 9Homo sapiens (human)0.0151
Histone deacetylase 5Homo sapiens (human)0.0049
Nuclear receptor corepressor 2Homo sapiens (human)0.0049

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuadrado-Tejedor, M; de Miguel, I; Espelosin, M; Estella-Hermoso de Mendoza, A; García-Barroso, C; Garcia-Osta, A; Haizhong, T; Musheng, X; Oyarzabal, J; Pérez-González, M; Rabal, O; Sáez, E; Sánchez-Arias, JA; Ugarte, A; Ursua, S; Wei, W1

Other Studies

1 other study(ies) available for tadalafil and quisinostat

ArticleYear
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.
    Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19

    Topics: Acetylation; Alzheimer Disease; Animals; Cell Line; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Design; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mice; Models, Molecular; Phosphodiesterase 5 Inhibitors

2016